IMAGe retweeted
🌍 Meet our stellar international faculty at #IMAGe2027!
📅 12–14 Feb | 📍 PGIMER, Chandigarh
Leading myeloma experts from the USA, UK, Singapore & SAARC region!
⏳ Abstract deadline: 30 Nov 2026
🔗 imagesociety.co.in/conferenc…
@DrPMPGI @UdayYanamandra @IndMyAcGp @Myeloma_Society
IMAGe retweeted
📣 Call for Abstracts | Indian Myeloma Congress 2027
📍 PGIMER Chandigarh | 12–14 Feb 2027
Deadline: 30 Nov 2026 ⏳
Showcase your work to myeloma experts & build momentum for IMS 2027, New Delhi!
imagesociety.co.in/conferenc…
@DrPMPGI
@UdayYanamandra
@IndMyAcGp
@Myeloma_Society
IMAGe retweeted
Advancing myeloma care across borders! 🇮🇳🌎
It was great sharing my perspectives on GPRC5D directed therapies & sequencing at #HemeNext 2.0 in Delhi!
And a very engaging panel with @DrPMPGI, @RahulDoc2, Nikhil M Kumar, @dbhurani, @SameerMelinkeri & @DrSubhaprakash.
Thank you, @drshrinidhi2020 & the @HemeNext team for the invitation and warm hospitality! #mmsm
IMAGe retweeted
Good science, familiar faces, and new connections at #IMS2026.
Always nice meeting and networking with colleagues from India on an international stage.
Loved meeting @mbeksac56, @A_Bobin and Aline Ramirez in person!
And still plenty of people I’ve followed on X for years left to finally meet!
#mmsm
IMAGe retweeted
A thorough analysis in access in Myeloma in LMIC-Gaps and more important solutions by @UdayYanamandra and others at #IMS26
#LMIC Thanks to IMS leadership for this initiative 🙏
IMAGe retweeted
A very relevant LMIC Breakfast Meeting at #IMS2026
Excellent moderation by Dr Shaji Kumar (@myelomaMD), with Dr Jelena Bila (@BilaJelena) presenting the Balkan experience particularly well.
Dr Uday Yanamandra (@UdayYanamandra) and @IndMyAcGp highlighted the LMIC survey: drug affordability and diagnostic access remain major barriers, but importantly, the discussion moved toward measurable solutions.
I raised two points close to our practice:
Access must be measurable AND caregiver burden must be part of the access conversation.
Encouraging to hear IMS President Prof Philippe Moreau @Myeloma_Society emphasise taking these findings forward and engaging with relevant authorities.
From identifying gaps → to measuring whether we actually close them.
IMAGe retweeted
The WoMMen of Myeloma are ready to hike the Scottish Highlands.
give.healthtree.org/campaign…
We are 14K shy of our target! So support us!
#MedTwitter #oncology #mmsm #hematolgy #research
IMAGe retweeted
Some work ends with publication.
Some quietly travels a little further.
Grateful to see our work on MRD in multiple myeloma receive the Editors’ Award 2025. Doi- doi.org/10.31547/bct-2025-00…
A small reminder that the questions worth asking often continue speaking long after the manuscript is finished.
#MultipleMyeloma #MRD #Hematology #Research @APBMT_BCT @IndMyAcGp @oncodaily @OncoAlert
IMAGe retweeted
We are pleased to announce the launch of a new academic initiative under IMAGe (@IndMyAcGp) — I‑PROBE (IMAGe Problem Case Review & Opinion Board for Plasma Cell DisordErs), a focused monthly webinar series.
Program Highlights:
• Expert insights from national and international leaders • Presentation of challenging myeloma cases
• Interactive discussions aimed at improving clinical outcomes
The inaugural session is scheduled for 13th August 2026, 5:30–6:30 PM (IST). Join us for expert-led case discussions in plasma cell disorders featuring Dr. Shaji Kumar (@myelomaMD), Lt. Gen (Dr.) Velu Nair (@DrVeluNair2), Dr. Rahul Bhargava (@RahulDoc2), and case presenter Dr. Mehak Trehan (@mehak_trehan).
#Myeloma #MedTwitter
IMAGe retweeted
New in #Clinical_lymphoma_Myeloma_Leukemia_journal : Validation of an open-source AI workflow (QuPath v0.6) for plasma cell quantification on CD138 IHC — the first such validation from India, using an Indian-made whole-slide scanner (OptraScan OS-Ultra). A significant work from the Department of Pathology, AFMC.
✅ ICC 0.995 vs manual reference count
✅ 100% sensitivity at all IMWG thresholds (≥10%, ≥30%, ≥60%)
✅ Narrow Bland-Altman limits (-3.0 to +7.8 pp), no proportional bias
✅ Outperformed overview estimation by hematopathologists
Open-source + locally manufactured scanner = a resource-appropriate digital pathology tool for Indian & South Asian hematopathology labs.
📄 doi.org/10.1016/j.clml.2026.…
#MultipleMyeloma #DigitalPathology #QuPath #Hematopathology #PlasmaCellNeoplasms #AIinMedicine #MedTwitter
IMAGe retweeted
The IMS is proud to present the new “Global Leadership Opportunity” or GLO to empower the next generation of myeloma leadership. Get ready to GLO with IMS and apply today: ow.ly/W0Z950YUuVl
IMAGe retweeted
If this is true then urgent rectification required.
Has the @CDSCO_INDIA_INF conveniently forgotten that there are #hematologists who are specially trained to treat #bloodcancers ? This order has surprised me as I was a member of the Subject Expert Committee of CDSCO on #HematologyOncology for more than 5 years. If CDSCO feels hematooncologists are not competent to conduct #clinicaltrials on patients with blood cancers then should we stop treating these patients ? @NMC_IND @MoHFW_INDIA @DrPMPGI @RahulDoc2 @drtulikahemat
IMAGe retweeted
The IMS is proud to present the new “Global Leadership Opportunity” or GLO to empower the next generation of myeloma leadership. Get ready to GLO with IMS and apply today: ow.ly/W0Z950YUuVl
IMAGe retweeted
☑️One last thing on your IMS 2026 to-do list: submit your abstract! ➡️bit.ly/41qoY0E #IMS26
IMAGe retweeted
Launched a WM FAQ booklet & helpline number today in collaboration with @IndMyAcGp @caregiversasha to support patients and families
@DrPMPGI @UdayYanamandra
#WMWorldAwarenessDay
IMAGe retweeted
Indian Myeloma Academic Group calls for nominations from India for the #6th IMF–AMN Masterclass, Singapore, from 2-5 July 2026! Full sponsorship for emerging hematologists & oncologists in India from @IndMyAcGp in coordination with @IMFmyeloma. Eligibility: Active @IndMyAcGp membership, DrNB/DM (≤5 yrs), myeloma clinical experience.
Deadline: 15 April 2026. A gateway to global expertise & AMN networking.
📩 Apply via IMAGe Secretariat. ([email protected])
@HariMenon68 @DrPMPGI @reenanair1 @DrVeluNair2 @KhattryNavin @MirghSumeet @DrNidhiJain6 @drssgundeti @dr_rajapramanik @Drshrestha88 @SaikiaTapa59062 @myelomaMD @VincentRK @theMMRF @Myeloma_Society @DrNikitaMehra @Prasshmehta @PrashantTembha1 @ReetuJain19 @drsanjeev1980 @Myelomafriends
IMAGe retweeted
The #IMS26 preliminary program is now available! View the schedule for Glasgow and register today ➡️ bit.ly/4cdFJkH
IMAGe retweeted
Medanta Noida marked Myeloma Awareness Month with the Medanta Noida Awareness Run – March for Myeloma 2026, bringing the community together to spread awareness about Myeloma, a type of blood cancer.
The strong participation reflected a shared commitment towards understanding the importance of early symptoms, timely diagnosis, and the right treatment for better outcomes in blood cancer care.
Through initiatives like these, Medanta continues to encourage greater awareness about blood cancers, empowering people to seek timely medical guidance and make informed health decisions.
#MyelomaAwarenessMonth #BloodCancerAwareness #MedantaNoida #AwarenessRun #CancerAwareness #Medanta
